158 related articles for article (PubMed ID: 34432478)
1. Inactivation of Coronaviruses during Sample Preparation for Proteomics Experiments.
Grossegesse M; Leupold P; Doellinger J; Schaade L; Nitsche A
J Proteome Res; 2021 Sep; 20(9):4598-4602. PubMed ID: 34432478
[TBL] [Abstract][Full Text] [Related]
2. Robust Evaluation of Ultraviolet-C Sensitivity for SARS-CoV-2 and Surrogate Coronaviruses.
Boegel SJ; Gabriel M; Sasges M; Petri B; D'Agostino MR; Zhang A; Ang JC; Miller MS; Meunier SM; Aucoin MG
Microbiol Spectr; 2021 Oct; 9(2):e0053721. PubMed ID: 34668746
[TBL] [Abstract][Full Text] [Related]
3. Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination Boosts Neutralizing Activity Against Seasonal Human Coronaviruses.
Lawrenz J; Xie Q; Zech F; Weil T; Seidel A; Krnavek D; van der Hoek L; Münch J; Müller JA; Kirchhoff F
Clin Infect Dis; 2022 Aug; 75(1):e653-e661. PubMed ID: 35079775
[TBL] [Abstract][Full Text] [Related]
4. Human Milk Antibodies Against S1 and S2 Subunits from SARS-CoV-2, HCoV-OC43, and HCoV-229E in Mothers with A Confirmed COVID-19 PCR, Viral SYMPTOMS, and Unexposed Mothers.
Demers-Mathieu V; DaPra C; Mathijssen G; A Sela D; M Jarvinen K; Seppo A; Fels S; Medo E
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33572480
[TBL] [Abstract][Full Text] [Related]
5. Fully automated detection and differentiation of pandemic and endemic coronaviruses (NL63, 229E, HKU1, OC43 and SARS-CoV-2) on the hologic panther fusion.
Cordes AK; Rehrauer WM; Accola MA; Wölk B; Hilfrich B; Heim A
J Med Virol; 2021 Jul; 93(7):4438-4445. PubMed ID: 33350484
[TBL] [Abstract][Full Text] [Related]
6. Improving human coronavirus OC43 (HCoV-OC43) research comparability in studies using HCoV-OC43 as a surrogate for SARS-CoV-2.
Schirtzinger EE; Kim Y; Davis AS
J Virol Methods; 2022 Jan; 299():114317. PubMed ID: 34634321
[TBL] [Abstract][Full Text] [Related]
7. The Stability of Model Human Coronaviruses on Textiles in the Environment and during Health Care Laundering.
Owen L; Shivkumar M; Laird K
mSphere; 2021 Apr; 6(2):. PubMed ID: 33910996
[TBL] [Abstract][Full Text] [Related]
8. An overview on the seven pathogenic human coronaviruses.
Kesheh MM; Hosseini P; Soltani S; Zandi M
Rev Med Virol; 2022 Mar; 32(2):e2282. PubMed ID: 34339073
[TBL] [Abstract][Full Text] [Related]
9. Pulsed blue light inactivates two strains of human coronavirus.
Enwemeka CS; Bumah VV; Mokili JL
J Photochem Photobiol B; 2021 Sep; 222():112282. PubMed ID: 34404018
[TBL] [Abstract][Full Text] [Related]
10. The durability of immunity against reinfection by SARS-CoV-2: a comparative evolutionary study.
Townsend JP; Hassler HB; Wang Z; Miura S; Singh J; Kumar S; Ruddle NH; Galvani AP; Dornburg A
Lancet Microbe; 2021 Dec; 2(12):e666-e675. PubMed ID: 34632431
[TBL] [Abstract][Full Text] [Related]
11. Neutralizing and binding activities against SARS-CoV-1/2, MERS-CoV, and human coronaviruses 229E and OC43 by normal human intravenous immunoglobulin derived from healthy donors in Japan.
Kubota-Koketsu R; Terada Y; Yunoki M; Sasaki T; Nakayama EE; Kamitani W; Shioda T
Transfusion; 2021 Feb; 61(2):356-360. PubMed ID: 33104267
[TBL] [Abstract][Full Text] [Related]
12. Mechanistic insights into SARS-CoV-2 epidemic via revealing the features of SARS-CoV-2 coding proteins and host responses upon its infection.
Qin S; Xia X; Shi X; Ji X; Ma F; Chen L
Bioinformatics; 2021 Jan; 36(21):5133-5138. PubMed ID: 32805023
[TBL] [Abstract][Full Text] [Related]
13. Etiology and clinical characteristics of SARS-CoV-2 and other human coronaviruses among children in Zhejiang Province, China 2017-2019.
Zhang Y; Su L; Chen Y; Yu S; Zhang D; Mao H; Fang L
Virol J; 2021 Apr; 18(1):89. PubMed ID: 33931105
[TBL] [Abstract][Full Text] [Related]
14. In vitro virucidal activity of Echinaforce®, an Echinacea purpurea preparation, against coronaviruses, including common cold coronavirus 229E and SARS-CoV-2.
Signer J; Jonsdottir HR; Albrich WC; Strasser M; Züst R; Ryter S; Ackermann-Gäumann R; Lenz N; Siegrist D; Suter A; Schoop R; Engler OB
Virol J; 2020 Sep; 17(1):136. PubMed ID: 32907596
[TBL] [Abstract][Full Text] [Related]
15. Brilacidin, a COVID-19 drug candidate, demonstrates broad-spectrum antiviral activity against human coronaviruses OC43, 229E, and NL63 through targeting both the virus and the host cell.
Hu Y; Jo H; DeGrado WF; Wang J
J Med Virol; 2022 May; 94(5):2188-2200. PubMed ID: 35080027
[TBL] [Abstract][Full Text] [Related]
16. Inactivation of SARS-CoV-2 and HCoV-229E in vitro by ColdZyme® a medical device mouth spray against the common cold.
Gudmundsdottir Á; Scheving R; Lindberg F; Stefansson B
J Med Virol; 2021 Mar; 93(3):1792-1795. PubMed ID: 32975843
[TBL] [Abstract][Full Text] [Related]
17. Cytopathic Effect Assay and Plaque Assay to Evaluate
Hu Y; Ma C; Wang J
Bio Protoc; 2022 Feb; 12(3):e4314. PubMed ID: 35284599
[TBL] [Abstract][Full Text] [Related]
18. Far-UVC light (222 nm) efficiently and safely inactivates airborne human coronaviruses.
Buonanno M; Welch D; Shuryak I; Brenner DJ
Sci Rep; 2020 Jun; 10(1):10285. PubMed ID: 32581288
[TBL] [Abstract][Full Text] [Related]
19. Effect of Jinzhen granule on two coronaviruses: The novel SARS-CoV-2 and the HCoV-229E and the evidences for their mechanisms of action.
Ma Q; Wang Z; Chen R; Lei B; Liu B; Jiang H; Chen Z; Cai X; Guo X; Zhou M; Huang J; Li X; Dai J; Yang Z
Phytomedicine; 2022 Jan; 95():153874. PubMed ID: 34923232
[TBL] [Abstract][Full Text] [Related]
20. Optimizing human coronavirus OC43 growth and titration.
Savoie C; Lippé R
PeerJ; 2022; 10():e13721. PubMed ID: 35833016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
